marketcaparena
Search

    SDGR

    Schrodinger, Inc.

    Company overview

    Market capitalization
    —
    Employees
    850
    Latest publication
    2026-09-29
    About Schrodinger, Inc.

    Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

    Company website

    Financial statements

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Total Assets634,187,000USD726,160,000USD653,660,000USD688,244,000USD743,032,000USD823,226,000USD669,296,000USD688,371,000USD
    Other Current Assets16,817,000USD19,408,000USD13,336,000USD27,026,000USD24,326,000USD27,536,000USD22,896,000USD19,720,000USD
    Total Liab320,639,000USD362,107,000USD332,308,000USD345,372,000USD369,528,000USD401,781,000USD219,871,000USD214,391,000USD
    Total Stockholder Equity313,548,000USD364,053,000USD321,352,000USD342,872,000USD373,504,000USD421,445,000USD449,425,000USD473,980,000USD
    Other Current Liab38,473,000USD48,419,000USD36,872,000USD35,585,000USD31,398,000USD52,382,000USD41,247,000USD34,043,000USD
    Common Stock654,000USD645,000USD737,000USD736,000USD734,000USD729,000USD729,000USD728,000USD
    Capital Stock746,000USD737,000USD737,000USD736,000USD734,000USD729,000USD729,000USD728,000USD
    Retained Earnings-688,832,000USD-628,806,000USD-661,317,000USD-628,522,000USD-585,349,000USD-525,541,000USD-485,325,000USD-447,189,000USD
    Good Will4,791,000USD4,791,000USD4,791,000USD4,791,000USD4,791,000USD4,791,000USD4,791,000USD4,791,000USD
    Cash260,255,000USD230,517,000USD181,873,000USD219,901,000USD325,997,000USD147,326,000USD160,416,000USD108,109,000USD
    Cash And Short Term Investments398,959,000USD395,464,000USD400,986,000USD450,185,000USD500,298,000USD352,124,000USD388,679,000USD377,289,000USD
    Total Current Assets463,959,000USD519,265,000USD471,722,000USD513,995,000USD570,944,000USD634,993,000USD456,398,000USD449,179,000USD
    Total Current Liabilities169,542,000USD189,136,000USD145,113,000USD155,769,000USD165,472,000USD191,747,000USD111,117,000USD99,759,000USD
    Current Deferred Revenue103,111,000USD112,853,000USD82,283,000USD94,543,000USD105,458,000USD111,944,000USD41,773,000USD40,799,000USD
    Net Debt-153,299,000USD-121,289,000USD-70,439,000USD-105,588,000USD-209,837,000USD-29,497,000USD-40,272,000USD15,820,000USD
    Short Term Debt16,013,000USD16,412,000USD16,739,999USD16,841,000USD16,755,000USD16,755,000USD16,887,000USD16,801,000USD
    Short Long Term Debt Total106,956,000USD109,228,000USD111,434,000USD114,313,000USD116,160,000USD117,829,000USD120,144,000USD123,929,000USD
    Long Term Investments39,826,000USD73,647,000USD44,382,000USD34,691,000USD30,113,000USD43,208,000USD65,216,000USD88,555,000USD
    Short Term Investments138,704,000USD164,947,000USD219,113,000USD230,284,000USD174,301,000USD204,798,000USD228,263,000USD269,180,000USD
    Net Receivables48,183,000USD104,393,000USD57,400,000USD36,784,000USD46,320,000USD255,333,000USD44,823,000USD52,170,000USD
    Accounts Payable11,945,000USD11,452,000USD9,218,000USD8,800,000USD11,861,000USD10,666,000USD11,210,000USD8,116,000USD
    Property Plant Equipment Net120,645,000USD122,192,000USD125,845,000USD129,055,000USD132,598,000USD136,079,000USD137,738,000USD142,248,000USD
    Property Plant Equipment Gross120,645,000USD147,190,000USD125,845,000USD129,055,000USD132,598,000USD156,933,000USD137,738,000USD142,248,000USD
    Accumulated Other Comprehensive Income-28,000USD107,000USD79,000USD-29,000USD90,000USD220,000USD597,000USD-180,000USD
    Common Stock Shares Outstanding73,989,137shares73,443,298shares73,613,090shares73,427,635shares73,058,000shares72,670,000shares72,813,000shares72,711,685shares
    Non Current Assets Total170,228,000USD206,895,000USD181,938,000USD174,249,000USD172,088,000USD188,233,000USD212,898,000USD239,192,000USD
    Non Current Liabilities Total151,097,000USD172,971,000USD187,195,000USD189,603,000USD204,056,000USD210,034,000USD108,754,000USD114,632,000USD
    Non Current Liabilities Other1,135,000USD1,278,000USD111,000USD136,000USD155,000USD146,000USD297,000USD424,000USD
    Non Currrent Assets Other4,966,000USD6,265,000USD6,920,000USD5,712,000USD4,586,000USD4,155,000USD5,153,000USD3,598,000USD
    Net Working Capital294,417,000USD330,129,000USD326,609,000USD358,226,000USD405,472,000USD443,246,000USD345,281,000USD349,420,000USD
    Unclassified Non Current Liabilities149,962,000USD171,693,000USD187,084,000USD189,467,000USD203,901,000USD209,888,000USD108,457,000USD114,208,000USD
    Unclassified Equity1,001,008,000USD991,370,000USD981,116,000USD969,951,000USD957,295,000USD945,308,000USD932,695,000USD919,893,000USD
    Inventory———————1USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets726,160,000USD823,226,000USD802,955,000USD688,587,000USD756,487,000USD746,263,000USD155,270,000USD120,730,000USD
    Other Current Assets19,408,000USD27,536,000USD15,677,000USD13,812,000USD8,030,000USD4,909,000USD6,968,000USD2,602,000USD
    Total Liab362,107,000USD401,781,000USD254,397,000USD240,682,000USD199,402,000USD122,244,000USD248,593,000USD192,290,000USD
    Total Stockholder Equity364,053,000USD421,445,000USD548,558,000USD447,894,000USD557,071,000USD624,015,000USD-93,364,000USD-71,560,000USD
    Other Current Liab48,419,000USD52,382,000USD43,759,000USD30,392,000USD25,722,000USD14,861,000USD10,858,000USD6,615,000USD
    Common Stock645,000USD729,000USD722,000USD714,000USD710,000USD699,000USD61,000USD59,000USD
    Capital Stock737,000USD729,000USD722,000USD714,000USD710,000USD699,000USD61,000USD59,000USD
    Retained Earnings-628,806,000USD-525,541,000USD-338,418,000USD-379,138,000USD-229,952,000USD-129,559,000USD-105,096,000USD-80,525,000USD
    Good Will4,791,000USD4,791,000USD4,791,000USD4,791,000USD0USD———
    Cash230,517,000USD147,326,000USD155,315,000USD90,474,000USD120,267,000USD202,296,000USD25,986,000USD77,716,000USD
    Cash And Short Term Investments395,464,000USD352,124,000USD463,003,000USD451,087,000USD576,479,000USD642,691,000USD85,830,000USD84,067,000USD
    Total Current Assets519,265,000USD634,993,000USD567,796,000USD533,989,000USD625,060,000USD682,978,000USD118,536,000USD104,690,000USD
    Total Current Liabilities189,136,000USD191,747,000USD133,673,000USD108,799,000USD91,211,000USD73,205,000USD45,020,000USD27,005,000USD
    Current Deferred Revenue112,853,000USD111,944,000USD56,231,000USD57,931,000USD55,368,000USD45,403,000USD25,054,000USD17,617,000USD
    Net Debt-121,289,000USD-29,497,000USD-27,433,000USD26,017,000USD-40,398,000USD-190,532,000USD-11,514,000USD-77,716,000USD
    Short Term Debt16,412,000USD16,755,000USD16,868,000USD11,006,000USD2,042,000USD4,543,000USD5,584,000USD—
    Short Long Term Debt Total109,228,000USD117,829,000USD127,882,000USD116,491,000USD79,869,000USD11,764,000USD14,472,000USD—
    Long Term Investments73,647,000USD43,208,000USD83,251,000USD25,683,000USD43,167,000USD45,664,000USD15,366,000USD5,444,000USD
    Short Term Investments164,947,000USD204,798,000USD307,688,000USD360,613,000USD456,212,000USD440,395,000USD59,844,000USD6,351,000USD
    Net Receivables104,393,000USD255,333,000USD89,116,000USD69,090,000USD40,551,000USD35,378,000USD25,738,000USD18,021,000USD
    Accounts Payable11,452,000USD10,666,000USD16,815,000USD9,470,000USD8,079,000USD8,398,000USD3,524,000USD2,773,000USD
    Property Plant Equipment Net122,192,000USD136,079,000USD141,103,000USD120,226,000USD85,409,000USD15,269,000USD19,030,000USD7,967,000USD
    Property Plant Equipment Gross147,190,000USD156,933,000USD159,253,000USD134,339,000USD85,409,000USD15,269,000USD19,030,000USD7,967,000USD
    Accumulated Other Comprehensive Income107,000USD220,000USD281,000USD-2,382,000USD-651,000USD317,000USD16,000USD-9,000USD
    Common Stock Shares Outstanding73,443,298shares72,670,000shares74,986,816shares71,173,419shares70,594,950shares60,024,658shares63,265,362shares48,465,649shares
    Non Current Assets Total206,895,000USD188,233,000USD235,159,000USD154,598,000USD131,427,000USD63,285,000USD36,734,000USD16,040,000USD
    Non Current Liabilities Total172,971,000USD210,034,000USD120,724,000USD131,883,000USD108,191,000USD49,039,000USD203,573,000USD165,285,000USD
    Non Current Liabilities Other1,278,000USD146,000USD667,000USD800,000USD78,127,000USD7,875,000USD900,000USD—
    Non Currrent Assets Other6,265,000USD4,155,000USD6,014,000USD3,311,000USD2,851,000USD2,352,000USD2,338,000USD2,614,000USD
    Net Working Capital330,129,000USD443,246,000USD434,123,000USD425,190,000USD533,849,000USD609,773,000USD73,516,000USD77,685,000USD
    Unclassified Non Current Liabilities171,693,000USD209,888,000USD120,057,000USD104,685,000USD-30,364,000USD-41,818,000USD199,568,000USD161,687,000USD
    Unclassified Equity991,370,000USD945,308,000USD885,251,000USD827,986,000USD786,254,000USD751,859,000USD11,594,000USD8,856,000USD
    Intangible Assets——4,791,000USD587,000USD———15,000USD
    Unclassified Non Current Assets——-4,791,000USD-3,311,000USD-2,851,000USD-2,352,000USD-2,338,000USD-2,614,000USD
    Other Liab———26,398,000USD30,364,000USD41,818,000USD3,105,000USD3,598,000USD
    Other Assets———3,311,000USD2,851,000USD2,352,000USD2,338,000USD2,614,000USD
    Inventory———-13,137,000USD-8,807,000USD-3,955,000USD1USD—
    Net Tangible Assets———442,516,000USD557,071,000USD624,015,000USD-93,364,000USD-71,575,000USD
    Deferred Long Term Liab————30,064,000USD41,164,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-60,026,000USD135,776,000USD-32,795,000USD-43,173,000USD-59,808,000USD-40,216,000USD-38,136,000USD-54,047,000USD
    Depreciation1,476,000USD1,437,000USD1,465,000USD1,531,000USD1,589,000USD1,764,000USD1,558,000USD1,401,000USD
    Stock Based Compensation9,073,000USD9,950,000USD10,846,000USD10,627,000USD11,574,000USD12,479,000USD12,398,000USD12,808,000USD
    Other Non Cash Items12,834,000USD-149,784,000USD-10,362,000USD-5,374,000USD12,234,000USD20,748,000USD-27,012,000USD3,817,000USD
    Change To Account Receivables56,210,000USD-46,993,000USD-20,616,000USD9,536,000USD209,013,000USD-210,510,000USD7,347,000USD-6,550,000USD
    Change In Working Capital21,809,000USD-13,472,000USD-31,027,000USD-15,809,000USD178,474,000USD-25,888,000USD17,936,000USD-17,702,000USD
    Total Cash From Operating Activities-14,834,000USD-16,093,000USD-61,873,000USD-52,198,000USD144,063,000USD-31,113,000USD-33,256,000USD-53,723,000USD
    Capital Expenditures-2,507,000USD-41,000USD-491,000USD-314,000USD-596,000USD-873,000USD-1,342,000USD-1,001,000USD
    Free Cash Flow-17,341,000USD-16,134,000USD-62,364,000USD-52,512,000USD143,467,000USD-31,986,000USD-34,598,000USD-54,724,000USD
    Investments26,772,000USD53,714,000USD11,459,000USD-55,601,000USD30,632,000USD23,475,000USD90,704,000USD29,578,000USD
    Total Cashflows From Investing Activities44,599,000USD71,408,000USD11,459,000USD-55,601,000USD30,632,000USD23,475,000USD90,704,000USD29,578,000USD
    Net Borrowings-14,000USD-15,000USD-14,000USD-15,000USD-14,000USD-15,000USD-14,000USD—
    Total Cash From Financing Activities569,000USD197,000USD307,000USD2,018,000USD409,000USD119,000USD392,000USD1,607,000USD
    Change In Cash30,334,000USD55,512,000USD-50,107,000USD-105,781,000USD175,104,000USD-7,519,000USD57,840,000USD-22,538,000USD
    Begin Period Cash Flow237,385,000USD181,873,000USD231,980,000USD337,761,000USD162,657,000USD170,176,000USD112,336,000USD134,874,000USD
    End Period Cash Flow267,719,000USD237,385,000USD181,873,000USD231,980,000USD337,761,000USD162,657,000USD170,176,000USD112,336,000USD
    Other Cashflows From Financing Activities569,000USD197,000USD321,000USD2,033,000USD423,000USD-43,000USD406,000USD558,000USD
    Unclassified Investing Cash Flow20,334,000USD17,735,000USD————4,342,000USD-1,999,000USD
    Issuance Of Capital Stock—0USD0USD0USD0USD177,000USD0USD1,064,000USD
    Other Cashflows From Investing Activities——————-3,000,000USD3,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-103,265,000USD-187,123,000USD40,720,000USD-149,186,000USD-101,219,000USD-26,637,000USD-25,681,000USD-28,425,000USD
    Depreciation6,022,000USD6,159,000USD5,552,000USD4,344,000USD2,847,000USD3,658,000USD3,640,000USD2,894,000USD
    Stock Based Compensation42,997,000USD49,903,000USD47,841,000USD39,630,000USD26,490,000USD10,545,000USD2,193,000USD1,313,000USD
    Other Non Cash Items-50,021,000USD-13,267,000USD-208,293,000USD6,907,000USD-3,464,000USD2,137,000USD-10,506,000USD-149,000USD
    Change To Account Receivables150,940,000USD-166,217,000USD-20,026,000USD-27,950,000USD-5,508,000USD-12,747,000USD-6,594,000USD-4,273,000USD
    Change In Working Capital118,166,000USD-13,040,000USD-22,553,000USD-21,378,000USD4,677,000USD59,176,000USD4,295,000USD281,000USD
    Total Cash From Operating Activities13,899,000USD-157,368,000USD-136,733,000USD-119,683,000USD-70,669,000USD16,757,000USD-26,059,000USD-23,711,000USD
    Capital Expenditures-1,442,000USD-7,311,000USD-13,403,000USD-8,014,000USD-7,167,000USD-2,538,000USD-1,836,000USD-5,259,000USD
    Free Cash Flow12,457,000USD-164,679,000USD-150,136,000USD-127,697,000USD-77,836,000USD14,219,000USD-27,895,000USD-28,970,000USD
    Investments41,605,000USD148,836,000USD193,034,000USD90,023,000USD-9,645,000USD-379,183,000USD-53,855,000USD11,194,000USD
    Total Cashflows From Investing Activities57,898,000USD148,836,000USD193,034,000USD90,023,000USD-16,812,000USD-381,721,000USD-53,855,000USD11,194,000USD
    Net Borrowings-58,000USD-58,000USD-19,000USD0USD0USD———
    Total Cash From Financing Activities2,931,000USD10,123,000USD9,048,000USD2,110,000USD7,952,000USD541,274,000USD28,684,000USD80,273,000USD
    Issuance Of Capital Stock0USD8,868,000USD0USD0USD0USD537,091,000USD30,442,000USD80,273,000USD
    Change In Cash74,728,000USD1,591,000USD65,349,000USD-27,550,000USD-79,529,000USD176,310,000USD-51,230,000USD67,756,000USD
    Begin Period Cash Flow162,657,000USD161,066,000USD95,717,000USD123,267,000USD202,796,000USD26,486,000USD77,716,000USD9,960,000USD
    End Period Cash Flow237,385,000USD162,657,000USD161,066,000USD95,717,000USD123,267,000USD202,796,000USD26,486,000USD77,716,000USD
    Other Cashflows From Financing Activities2,931,000USD1,313,000USD9,067,000USD2,110,000USD7,952,000USD4,183,000USD28,684,000USD159,650,000USD
    Unclassified Investing Cash Flow17,735,000USD7,311,000USD-133,810,000USD-3,811,000USD—-4,582,000USD—8,906,000USD
    Other Cashflows From Investing Activities——147,213,000USD11,825,000USD375,000USD4,582,000USD943,000USD-3,647,000USD
    Change To Liabilities———-724,000USD8,456,000USD68,343,000USD6,421,000USD8,413,000USD
    Change To Inventory————6,437,000USD7,336,000USD2,912,000USD-3,859,000USD
    Sale Purchase Of Stock————7,952,000USD215,674,000USD30,442,000USD80,273,000USD
    Cash And Cash Equivalents Changes————-79,529,000USD176,310,000USD——
    Unclassified Financing Cash Flow————-7,952,000USD321,417,000USD-30,442,000USD-159,650,000USD
    Unclassified Operating Cash Flow—————-32,122,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31GeographyAPAC6,673,000USD0001490978-26-000037
    Q1 2026Quarterly · 2026-03-31GeographyEMEA20,173,000USD0001490978-26-000037
    Q1 2026Quarterly · 2026-03-31GeographyInternational333,000USD0001490978-26-000037
    Q1 2026Quarterly · 2026-03-31GeographyUnited States31,408,000USD0001490978-26-000037
    Q1 2026Quarterly · 2026-03-31ProductDrug Discovery22,879,000USD0001490978-26-000037
    Q1 2026Quarterly · 2026-03-31ProductHosted Software12,080,000USD0001490978-26-000037
    Q1 2026Quarterly · 2026-03-31ProductOn Premise Software14,180,000USD0001490978-26-000037
    Q1 2026Quarterly · 2026-03-31ProductOther148,000USD0001490978-26-000037
    Q1 2026Quarterly · 2026-03-31ProductProfessional Services2,638,000USD0001490978-26-000037
    Q1 2026Quarterly · 2026-03-31ProductSoftware Contribution0USD0001490978-26-000037
    Q1 2026Quarterly · 2026-03-31ProductSoftware Products And Services — Maintenance6,662,000USD0001490978-26-000037
    Q1 2026Quarterly · 2026-03-31SegmentDrug Discovery23,027,000USD0001490978-26-000037
    Q1 2026Quarterly · 2026-03-31SegmentSoftware35,560,000USD0001490978-26-000037
    Q4 2025Quarterly · 2025-12-31GeographyAPAC6,381,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyEMEA22,795,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyInternational140,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyUnited States57,919,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentDrug Discovery17,953,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentSoftware69,282,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyAPAC26,181,000USD0001490978-26-000010
    FY 2025Yearly · 2025-12-31GeographyEMEA75,164,000USD0001490978-26-000010
    FY 2025Yearly · 2025-12-31GeographyInternational1,561,000USD0001490978-26-000010
    FY 2025Yearly · 2025-12-31GeographyUnited States152,963,000USD0001490978-26-000010
    FY 2025Yearly · 2025-12-31ProductDrug Discovery Services54,760,000USD0001490978-26-000010
    FY 2025Yearly · 2025-12-31ProductHosted Software45,123,000USD0001490978-26-000010
    FY 2025Yearly · 2025-12-31ProductOn Premise Software101,448,000USD0001490978-26-000010
    FY 2025Yearly · 2025-12-31ProductOncology Neurology And Immunology Product2,800,000USD0001490978-26-000010
    FY 2025Yearly · 2025-12-31ProductOther14,797,000USD0001490978-26-000010
    FY 2025Yearly · 2025-12-31ProductRevenue From Contract With Customer Before Software Contribution — Maintenance27,293,000USD0001490978-26-000010
    FY 2025Yearly · 2025-12-31ProductRevenue From Contract With Customer Before Software Contribution — Professional Services9,648,000USD0001490978-26-000010
    FY 2025Yearly · 2025-12-31SegmentDrug Discovery56,369,000USD0001490978-26-000010
    FY 2025Yearly · 2025-12-31SegmentSoftware199,500,000USD0001490978-26-000010
    Q3 2025Quarterly · 2025-09-30GeographyAPAC6,755,000USD0001490978-25-000117
    Q3 2025Quarterly · 2025-09-30GeographyEMEA15,723,000USD0001490978-25-000117
    Q3 2025Quarterly · 2025-09-30GeographyInternational515,000USD0001490978-25-000117
    Q3 2025Quarterly · 2025-09-30GeographyUnited States31,331,000USD0001490978-25-000117
    Q3 2025Quarterly · 2025-09-30ProductDrug Discovery Services13,008,000USD0001490978-25-000117
    Q3 2025Quarterly · 2025-09-30ProductOther5,388,000USD0001490978-25-000117
    Q3 2025Quarterly · 2025-09-30ProductRevenue From Contract With Customer Before Contribution — Hosted Software11,585,000USD0001490978-25-000117
    Q3 2025Quarterly · 2025-09-30ProductRevenue From Contract With Customer Before Contribution — Maintenance6,826,000USD0001490978-25-000117
    Q3 2025Quarterly · 2025-09-30ProductRevenue From Contract With Customer Before Contribution — On Premise Software15,928,000USD0001490978-25-000117
    Q3 2025Quarterly · 2025-09-30ProductRevenue From Contract With Customer Before Contribution — Professional Services1,589,000USD0001490978-25-000117
    Q3 2025Quarterly · 2025-09-30SegmentDrug Discovery13,466,000USD0001490978-25-000117
    Q3 2025Quarterly · 2025-09-30SegmentSoftware40,858,000USD0001490978-25-000117
    Q2 2025Quarterly · 2025-06-30GeographyAPAC6,971,000USD0001490978-25-000100
    Q2 2025Quarterly · 2025-06-30GeographyEMEA13,563,000USD0001490978-25-000100
    Q2 2025Quarterly · 2025-06-30GeographyInternational175,000USD0001490978-25-000100
    Q2 2025Quarterly · 2025-06-30GeographyUnited States34,050,000USD0001490978-25-000100
    Q2 2025Quarterly · 2025-06-30ProductDrug Discovery Services13,940,000USD0001490978-25-000100
    Q2 2025Quarterly · 2025-06-30ProductOther4,788,000USD0001490978-25-000100
    Q2 2025Quarterly · 2025-06-30ProductRevenue From Contract With Customer Before Contribution — Hosted Software11,128,000USD0001490978-25-000100
    Q2 2025Quarterly · 2025-06-30ProductRevenue From Contract With Customer Before Contribution — Maintenance6,778,000USD0001490978-25-000100
    Q2 2025Quarterly · 2025-06-30ProductRevenue From Contract With Customer Before Contribution — On Premise Software15,743,000USD0001490978-25-000100
    Q2 2025Quarterly · 2025-06-30ProductRevenue From Contract With Customer Before Contribution — Professional Services2,382,000USD0001490978-25-000100
    Q2 2025Quarterly · 2025-06-30SegmentDrug Discovery14,215,000USD0001490978-25-000100
    Q2 2025Quarterly · 2025-06-30SegmentSoftware40,544,000USD0001490978-25-000100
    Q1 2025Quarterly · 2025-03-31GeographyAPAC6,074,000USD0001490978-26-000037
    Q1 2025Quarterly · 2025-03-31GeographyEMEA23,083,000USD0001490978-26-000037
    Q1 2025Quarterly · 2025-03-31GeographyInternational731,000USD0001490978-26-000037
    Q1 2025Quarterly · 2025-03-31GeographyUnited States29,663,000USD0001490978-26-000037
    Q1 2025Quarterly · 2025-03-31ProductDrug Discovery10,236,000USD0001490978-26-000037
    Q1 2025Quarterly · 2025-03-31ProductDrug Discovery Contribution499,000USD0001490978-26-000037
    Q1 2025Quarterly · 2025-03-31ProductHosted Software10,872,000USD0001490978-26-000037
    Q1 2025Quarterly · 2025-03-31ProductOn Premise Software25,423,000USD0001490978-26-000037
    Q1 2025Quarterly · 2025-03-31ProductProfessional Services1,881,000USD0001490978-26-000037
    Q1 2025Quarterly · 2025-03-31ProductSoftware Contribution3,844,000USD0001490978-26-000037
    Q1 2025Quarterly · 2025-03-31ProductSoftware Products And Services — Maintenance6,796,000USD0001490978-26-000037
    Q1 2025Quarterly · 2025-03-31SegmentDrug Discovery10,735,000USD0001490978-26-000037
    Q1 2025Quarterly · 2025-03-31SegmentSoftware48,816,000USD0001490978-26-000037
    Q4 2024Quarterly · 2024-12-31GeographyAPAC7,216,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyEMEA44,600,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyInternational250,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States36,251,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentDrug Discovery8,655,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentSoftware79,662,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyAPAC25,802,000USD0001490978-26-000010
    FY 2024Yearly · 2024-12-31GeographyEMEA65,650,000USD0001490978-26-000010
    FY 2024Yearly · 2024-12-31GeographyInternational1,218,000USD0001490978-26-000010
    FY 2024Yearly · 2024-12-31GeographyUnited States114,869,000USD0001490978-26-000010
    FY 2024Yearly · 2024-12-31ProductDrug Discovery Services25,143,000USD0001490978-26-000010
    FY 2024Yearly · 2024-12-31ProductHosted Software35,253,000USD0001490978-26-000010
    FY 2024Yearly · 2024-12-31ProductOn Premise Software104,020,000USD0001490978-26-000010
    FY 2024Yearly · 2024-12-31ProductOncology Neurology And Immunology Product10,800,000USD0001490978-26-000010
    FY 2024Yearly · 2024-12-31ProductRevenue From Contract With Customer Before Software Contribution — Maintenance23,279,000USD0001490978-26-000010
    FY 2024Yearly · 2024-12-31ProductRevenue From Contract With Customer Before Software Contribution — Professional Services9,797,000USD0001490978-26-000010
    FY 2024Yearly · 2024-12-31SegmentDrug Discovery27,174,000USD0001490978-26-000010
    FY 2024Yearly · 2024-12-31SegmentSoftware180,365,000USD0001490978-26-000010
    Q3 2024Quarterly · 2024-09-30GeographyAPAC5,280,000USD0001490978-25-000117
    Q3 2024Quarterly · 2024-09-30GeographyEMEA5,145,000USD0001490978-25-000117
    Q3 2024Quarterly · 2024-09-30GeographyInternational243,000USD0001490978-25-000117
    Q3 2024Quarterly · 2024-09-30GeographyUnited States24,622,000USD0001490978-25-000117
    Q3 2024Quarterly · 2024-09-30ProductDrug Discovery Services2,813,000USD0001490978-25-000117
    Q3 2024Quarterly · 2024-09-30ProductOther3,717,000USD0001490978-25-000117
    Q3 2024Quarterly · 2024-09-30ProductRevenue From Contract With Customer Before Contribution — Hosted Software8,814,000USD0001490978-25-000117
    Q3 2024Quarterly · 2024-09-30ProductRevenue From Contract With Customer Before Contribution — Maintenance5,658,000USD0001490978-25-000117
    Q3 2024Quarterly · 2024-09-30ProductRevenue From Contract With Customer Before Contribution — On Premise Software12,250,000USD0001490978-25-000117
    Q3 2024Quarterly · 2024-09-30ProductRevenue From Contract With Customer Before Contribution — Professional Services2,038,000USD0001490978-25-000117
    Q3 2024Quarterly · 2024-09-30SegmentDrug Discovery3,406,000USD0001490978-25-000117
    Q3 2024Quarterly · 2024-09-30SegmentSoftware31,884,000USD0001490978-25-000117
    Q2 2024Quarterly · 2024-06-30GeographyAPAC7,805,000USD0001490978-25-000100

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.